There is no established human dosing , and clinical evidence remains limited
The 2023 American Diabetes Association Standards of Care emphasize that GLP-1 receptor agonists are first-line agents for type 2 diabetes management and cardiovascular risk reduction
These mechanisms of action overlap significantly with the therapeutic targets of phytomedicines
As of February 23, 2026, the manufacturer has a promotion for the Zepbound Self Pay Journey Program, which lowers rates to $449 for each 1-month supply of the 7.5 mg, 10 mg, 12.5 mg, and 15 mg Zepbound single-dose vial or Zepbound KwikPen for single-patient-use
Our team can help determine which option may be most appropriate based on your symptoms, goals, and treatment preferences, explore our full Glutathione page